NewsSOS
Eli Lilly's weight-loss pill Foundayo has received regulatory approval in the United Kingdom, the drug's first clearance outside the United States.
The decision carries Lilly's competition with Novo Nordisk's Wegovy beyond a single market, opening a second front in a rivalry that until now has played out on American soil.
Foundayo's first international approval Foundayo and Novo Nordisk's Wegovy have competed in the United States as rival entries in the weight-loss pill category.
Britain now becomes the second country where Lilly holds regulatory clearance for the drug. That is the transmission the U.K. decision represents: a domestic contest, extended.
Keep reading